Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Very Short Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy in Older Patients Undergoing Percutaneous Coronary Intervention (SOLOPCI)

NCT07164859 is registered in ClinicalTrials.gov with Vincent ROULE as lead sponsor.

NCT NCT07164859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07164859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Very Short Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy in Older Patients Undergoing Percutaneous Coronary Intervention (SOLOPCI)
Lead sponsor
Vincent ROULE
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
October 31, 2029
Enrollment
1,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet therapy, coronary artery disease (cad), elderly (people aged 65 or more), percutaneous coronary intervention (pci)